Yep. It just seems a little unusual they would shedule a presentation prior to hearing back from the FDA, when they could wait a few days, absorb the info and then shedule it. [unless they have had verbal discussions indicating what may be in the official letter]
A mid year update, 9 weeks after the last mid year update ? Why not call it an update on the IND progression ?
The Announcement was almost a cut and paste from Dec 5th, with a small variation.
5 December 2024 The webinar, hosted by Managing Director and Chief Executive Officer Dr. Michael Thurn, will offer valuable insights into Neurizon’s recent achievements, ongoing clinical progress, and strategic priorities
11 February 2025 The webinar, hosted by Managing Director and Chief Executive Officer Dr. Michael Thurn, will offer valuable insights into Neurizon’s recent developments, ongoing progress, and strategic priorities.
We know they have been working on a number of things, so we may get something new. Or Maybe not.
Just speculating, but that is what we do. Fingers crossed.
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)